Your insights were simply invaluable and recognized as such by all the scientists…

… Hiring you brought in-depth IP-based strategic analysis that not only helped gene therapy research and manufacturing development, but served multiple research groups within the company. Your help enabled gene therapy and research scientists to guide justifications for new scientific programs and areas of research, Your contributions demonstrated your unique value supporting and enhancing biology driven innovation that focused and enabled chemistry to prolifically generate unique drug candidates.

You are able to simplify complex science, succinctly package it in the context of IP (not easily done for granted and necessarily nuanced claims in certain competitive fields), and enable everyone in your audience to clearly see the path forward for a program or to clearly understand where the hidden obstacles lay that could sideline a program. Your scientific IP insights teased out possible paths forward, exposed the risks, gave guidance within the law on how to proceed and helped stakeholders make informed decisions.

Your insights were simply invaluable and recognized as such by all the scientists and by all corporate decision-makers. You didn’t have to ask to be included in team meetings, you were enviably indispensable. I watched you point out hidden faults and risks, weaknesses of potential programs that would have eventually led to discontinuing the program anyway, thus saving the company millions…

— Paul Martin, Vice President, Intellectual Property and Deputy General Counsel PTC Therapeutics
Prior results do not guarantee a similar outcome.